Geneva
For thousands of years an undesirable and persistent companion has been travelling with man wherever he goes.
CINCINNATI -- The effectiveness of pandemic flu vaccination campaigns -- like that now underway for H1N1 -- could be undermined by the public incorrectly associating coincidental and unrelated h
"HARPS is a unique, extremely high precision instrument that is ideal for discovering alien worlds," says Stéphane Udry, who made the announcement. "We have now completed our initial five-year programme, which has succeeded well beyond our expectations."
Prostate cancer patients of low socioeconomic status are more likely to die than patients with higher incomes. That is the finding of a new study from Swiss researchers to be published in the December 1, 2009 issue of Cancer, a peer-reviewed journal of the American Cancer Society.
Scientists in Switzerland have discovered a way to block the growth of human colon cancer cells, preventing the disease from reaching advanced stages and the development of liver metastases.
Targeted investments in climate science could lead to major benefits in reducing the costs of adapting to a changing climate, according to new research published by scientists from the UK's National Centre for Atmospheric Science (NCAS).
NASA's space shuttle program is winding down. With only about half a dozen more flights, shuttle crews will put the finishing touches on the International Space Station (ISS), bringing to an end twelve years of unprecedented orbital construction. The icon and workhorse of the American space program will have finished its Great Task.
Geneva, 6 August 2009. CERN 's Large Hadron Collider will initially run at an energy of 3.5 TeV per beam when it starts up in November this year. This news comes after all tests on the machine's high-current electrical connections were completed last week, indicating that no further repairs are necessary for safe running.
Geneva, Switzerland -- The 40 member organizations of the International Tiger Coalition (ITC) applaud remarks by the World Bank today stating that legalizing tiger farming is too great a gamble for the world to take if tigers are to have a future in the wild.
June 24/Geneva -- Climate has always presented a challenge to farmers, herders, fishermen and others whose livelihoods are closely linked to their environment, particularly those in poor areas of the world.
Soeren Prell admits to being amused by some of the high energy physics portrayed in “Angels & Demons,” the summer thriller starring science, religion and Tom Hanks.
Take, for example, scenes depicting CERN, the European Organization for Nuclear Research near Geneva, Switzerland, and its Large Hadron Collider, the $8 billion, 17-miles-around particle accelerator.
[Mechelen Belgium, June 3, 2009] ?Interim results from an ongoing phase 2, randomized, placebo-controlled trial of the investigational drug TMC207 for the treatment of multidrug-resistant tuberculosis (MDR-TB) were published in the New England Journal of Medicine today. TMC207 is being developed by Tibotec BVBA.
Troy, N.Y. ? What happens if the next big influenza mutation proves resistant to the available anti-viral drugs? This question is presenting itself right now to scientists and health officials this week at the World Health Assembly in Geneva, Switzerland, as they continue to do battle with H1N1, the so-called swine flu, and prepare for the next iteration of the ever-changing flu virus.
Countries and policy leaders gain new guidance today on how and when to eliminate malaria, paving the way for the potential global eradication of the deadly disease. The announcement is being made on behalf of the Malaria Elimination Group, a global body of researchers, policy experts and country program managers, by the Global Health Group of UCSF Global Health Sciences.
GENEVA/LAUSANNE - Researchers from the Universities of Geneva and Lausanne, as well as the Swiss Institute of Bioinformatics have been part of a major international project to sequence the bovine (cow) genome, a female Hereford cow named L1 Dominette.